Mei Pharma Inc   (MEIP)
Other Ticker:  


Mei Pharma Inc

MEIP's Financial Statements and Analysis

Mei Pharma Inc narrowed I. Quarter net loss per share of $-0.12 compare to net loss per share of $-0.18 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.13 realized in previous quarter.

I. Quarter
Earnings Per Share Revenues
$ -0.12 $  9 Mill
$+0.06     $+1M     +12.54 %

Mei Pharma Inc 's Revenue rose by 12.54 % in I. Quarter (Sep 30 2022) year on year, to $9 million and declined by -23.51 % sequentially.

Mei Pharma Inc is Expected to report next financial results on February 09, 2023.

More on MEIP's Income Statement

Mei Pharma Inc 's in I. Quarter recorded net loss of $-16.624 million, an improvement compare to net loss of $-17.510 million in I. Quarter a year ago.

Sequentially net loss advanced

More on MEIP's Growth

In I. Quarter company's net cash and cash equivalents decreased by $-1 million, capital expenditures fell by 687.50%, to $0 millions compare to same quarter a year ago and rose by -79.41% from IV. Quarter (Jun 30 2022).

More on MEIP's Cash flow Statement

Mei Pharma Inc does not pay out common stock dividend.

In trailing twelve-month period Mei Pharma Inc payed $ -0.42 cash per share, on a free-cash flow basis .